Suppr超能文献

肝细胞癌的临终关怀:姑息治疗和社会因素如何影响治疗及成本。

End-of-life in Hepatocellular Carcinoma: How Palliative Care and Social Factors Impact Care and Cost.

作者信息

Goble Spencer R, Sultan Amir, Debes Jose D

机构信息

Division of Gastroenterology, Department of Medicine, Hepatology, and Nutrition, University of Minnesota.

Department of Medicine, University of Minnesota, Mayo Memorial Building, Minneapolis, MN.

出版信息

J Clin Gastroenterol. 2024 Oct 24. doi: 10.1097/MCG.0000000000002091.

Abstract

OBJECTIVE

Investigate the impacts of palliative care consults, race, and socioeconomic status on the prevalence of invasive procedures in patients with hepatocellular carcinoma (HCC).

BACKGROUND

Palliative care, race, and socioeconomic status can all influence end-of-life care preferences, but their roles in HCC have not been adequately explored.

MATERIALS AND METHODS

This is a cross-sectional study of patients with HCC from 2016 to 2019 using the National Inpatient Sample. Terminal and nonterminal hospitalizations were assessed with logistical regression evaluating associations between palliative care, race, income, and procedures along with do-not-resuscitate orders and cost. Procedures included mechanical ventilation, tracheostomy, and cardiopulmonary resuscitation (CPR) among others.

RESULTS

A total of 217,060 hospitalizations in patients with HCC were included, 18.1% of which included a palliative care encounter. The mean age was 65.0 years (SD = 11.3 y), 73.9% were males and 55.5% were white. Procedures were increased in terminal hospitalizations in black [CPR adjusted odds ratio (aOR) = 2.57, P < 0.001] and Hispanic patients (tracheostomy aOR = 3.64, P = 0.018) compared with white patients. Palliative care encounters were associated with reduced procedures during terminal hospitalizations (mechanical ventilation aOR = 0.47, P < 0.001, CPR aOR = 0.24, P < 0.001), but not in nonterminal hospitalizations. No association between income and end-of-life procedures was found. Palliative care was associated with decreased mean cost in terminal ($23,608 vs $31,756, P < 0.001) and nonterminal hospitalizations ($15,786 vs $19,914, P < 0.001).

CONCLUSIONS

Palliative care is associated with less aggressive end-of-life care and decreased costs in patients with HCC. Black and Hispanic race were both associated with more aggressive end-of-life care.

摘要

目的

研究姑息治疗会诊、种族和社会经济地位对肝细胞癌(HCC)患者侵入性操作发生率的影响。

背景

姑息治疗、种族和社会经济地位都会影响临终关怀偏好,但它们在HCC中的作用尚未得到充分研究。

材料与方法

这是一项使用全国住院患者样本对2016年至2019年HCC患者进行的横断面研究。通过逻辑回归评估姑息治疗、种族、收入和操作之间的关联,以及不复苏医嘱和费用,对终末期和非终末期住院情况进行评估。操作包括机械通气、气管切开术和心肺复苏(CPR)等。

结果

共纳入217,060例HCC患者的住院病例,其中18.1%包括姑息治疗会诊。平均年龄为65.0岁(标准差=11.3岁),73.9%为男性,55.5%为白人。与白人患者相比,黑人患者(CPR调整优势比[aOR]=2.57,P<0.001)和西班牙裔患者(气管切开术aOR=3.64,P=0.018)在终末期住院时的操作增加。姑息治疗会诊与终末期住院期间操作减少相关(机械通气aOR=0.47,P<0.001,CPR aOR=0.24,P<0.001),但在非终末期住院时无此关联。未发现收入与临终操作之间存在关联。姑息治疗与终末期(23,608美元对31,756美元,P<0.001)和非终末期住院(15,786美元对19,914美元,P<0.001)的平均费用降低相关。

结论

姑息治疗与HCC患者临终关怀的积极性降低和费用减少相关。黑人及西班牙裔种族均与更积极的临终关怀相关。

相似文献

3
End-of-Life Care Among Patients With Neuroendocrine Tumors: Underutilization of Palliative Care and Racial Disparities.
J Natl Compr Canc Netw. 2025 Jun 12;23(8):314-318. doi: 10.6004/jnccn.2025.7024.
9
Gene therapy for people with hepatocellular carcinoma.肝细胞癌的基因治疗。
Cochrane Database Syst Rev. 2024 Jun 4;6(6):CD013731. doi: 10.1002/14651858.CD013731.pub2.
10
Palliative care interventions in advanced dementia.晚期痴呆症的姑息治疗干预措施。
Cochrane Database Syst Rev. 2016 Dec 2;12(12):CD011513. doi: 10.1002/14651858.CD011513.pub2.

本文引用的文献

3
Barriers to palliative care in hepatocellular carcinoma: A review of the literature.肝细胞癌姑息治疗的障碍:文献回顾。
J Gastroenterol Hepatol. 2023 Jul;38(7):1047-1055. doi: 10.1111/jgh.16107. Epub 2023 Jan 23.
4
Advanced hepatocellular carcinoma and palliative care: a scoping review.晚期肝细胞癌与姑息治疗:一项范围综述
BMJ Support Palliat Care. 2024 May 17;14(2):163-170. doi: 10.1136/spcare-2022-003798.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验